Volume 13 Issue 2
Mar.  2022
Turn off MathJax
Article Contents
Article Navigation >  ORGAN TRANSPLANTATION  > 2022  >  13(2): 135-143
Branch of Organ Transplantation of Chinese Medical Association, National Kidney Transplantation Quality Control Center. Technical specification for clinical diagnosis and treatment of human parvovirus B19 infection in kidney transplant recipients (2022 edition)[J]. ORGAN TRANSPLANTATION, 2022, 13(2): 135-143. doi: 10.3969/j.issn.1674-7445.2022.02.001
Citation: Branch of Organ Transplantation of Chinese Medical Association, National Kidney Transplantation Quality Control Center. Technical specification for clinical diagnosis and treatment of human parvovirus B19 infection in kidney transplant recipients (2022 edition)[J]. ORGAN TRANSPLANTATION, 2022, 13(2): 135-143. doi: 10.3969/j.issn.1674-7445.2022.02.001
shu

Technical specification for clinical diagnosis and treatment of human parvovirus B19 infection in kidney transplant recipients (2022 edition)

doi: 10.3969/j.issn.1674-7445.2022.02.001

  • The 3th Medical Center of Chinese People's Liberation Army General Hospital, Beijing 100039, China

  • Received Date: 2022-01-02
    Available Online: 2022-03-18
  • Publish Date: 2022-03-15
    Abstract
  • Long-term use of immunosuppressant in kidney transplant recipients leads to poor immune function and infection with various pathogens. In recent years, along with the advancement of detection technique of human parvovirus B19 (HPV-B19) infection and the increasing quantity of kidney transplantation, the infection rate of HPV-B19 after kidney transplantation has been elevated year by year, becoming one of the major causes of pure red cell aplasia (PRCA), affecting the recovery of renal allograft function, and even leading to the injury or poor prognosis of renal allograft. To further standardize the diagnosis and treatment of HPV-B19 infection in kidney transplant recipients, Branch of Organ Transplantation of Chinese Medical Association and National Kidney Transplantation Quality Control Center jointly organized experts to formulate the clinical diagnosis and treatment specification for HPV-B19 infection after kidney transplantation from the perspectives of etiology, epidemiological characteristics, clinical manifestations, diagnosis, prevention, treatment, existing problems and prospects of HPV-B19, aiming to provide guidance for standardized prevention and treatment of HPV-B19 infection post-kidney transplantation in China.

     

    • Corresponding author: Shi Bingyi, Email：shibingyi@medmail.com.cn
    FullText(HTML)
  • loading
    • References(37)
  • [1]
    LOBBES H, MAHÉVAS M, ALVISET S, et al. Pure red cell aplasia in systemic lupus erythematosus, a nationwide retrospective cohort and review of the literature[J]. Rheumatology (Oxford), 2021, 61(1): 355-366. DOI: 10.1093/rheumatology/keab363.
    [2]
    REZAHOSSEINI O, EKENBERG C, MØLLER DL, et al. Incidence and impact of parvovirus B19 infection in seronegative solid organ transplant recipients[J]. J Infect Dis, 2021, 224(5): 865-869. DOI: 10.1093/infdis/jiab024.
    [3]
    EID AJ, ARDURA MI, AST Infectious Diseases Community of Practice. Human parvovirus B19 in solid organ transplantation: guidelines from the American Society of Transplantation Infectious Diseases Community of Practice[J]. Clin Transplant, 2019, 33(9): e13535. DOI: 10.1111/ctr.13535.
    [4]
    涂金鹏. 实体器官移植术后人微小病毒B19感染研究进展[J/CD]. 泌尿外科杂志(电子版), 2021, 13(2): 15-18. DOI: 10.3969/j.issn.1674-7410.2021.02.004.

    TU JP. Research progress on human parvovirus B19 infection after solid organ transplantation[J/CD]. J Urol Clin(Electr Vers), 2021, 13(2): 15-18. DOI: 10.3969/j.issn.1674-7410.2021.02.004.j.issn.1674-7410.2021.02.004.
    [5]
    GARCIA RCNC, LEON LA. Human parvovirus B19: a review of clinical and epidemiological aspects in Brazil[J]. Future Microbiol, 2021, 16(1): 37-50. DOI: 10.2217/fmb-2020-0123.
    [6]
    GANAIE SS, QIU J. Recent advances in replication and infection of human parvovirus B19[J]. Front Cell Infect Microbiol, 2018, 8: 166. DOI: 10.3389/fcimb.2018.00166.
    [7]
    BROWN KE, HIBBS JR, GALLINELLA G, et al. Resistance to parvovirus B19 infection due to lack of virus receptor (erythrocyte P antigen)[J]. N Engl J Med, 1994, 330(17): 1192-1196. DOI: 10.1056/NEJM199404283301704.
    [8]
    NOURI M, KAMAKIFAR P, KHODABANDEHLOU N, et al. Association between parvovirus B19 and anemia in HIV-infected patients[J]. Med J Islam Repub Iran, 2019, 33: 137. DOI: 10.34171/mjiri.33.137.
    [9]
    段继惠, 穆红, 唐志琴, 等. 肾移植受者感染人类细小病毒B19后对T淋巴细胞的影响[J]. 中华实验外科杂志, 2014, 31(4): 902. DOI: 10.3760/cma.j.issn.1001-9030.2014.04.083.

    DUAN JH, MU H, TANG ZQ, et al. Effect of renal transplant recipients infected with human parvovirus B19 on T lymphocytes[J]. Chin J Exp Surg, 2014, 31(4): 902. DOI: 10.3760/cma.j.issn.1001-9030.2014.04.083.
    [10]
    SIM JY, CHANG LY, CHEN JM, et al. Human parvovirus B19 infection in patients with or without underlying diseases[J]. J Microbiol Immunol Infect, 2019, 52(4): 534-541. DOI: 10.1016/j.jmii.2019.05.009.
    [11]
    KI CS, KIM IS, KIM JW, et al. Incidence and clinical significance of human parvovirus B19 infection in kidney transplant recipients[J]. Clin Transplant, 2005, 19(6): 751-755. DOI: 10.1111/j.1399-0012.2005.00415.x.
    [12]
    GOSSET C, VIGLIETTI D, HUE K, et al. How many times can parvovirus B19-related anemia recur in solid organ transplant recipients?[J]. Transpl Infect Dis, 2012, 14(5): E64-E70. DOI: 10.1111/j.1399-3062.2012.00773.x.
    [13]
    张欢, 肖霞, 李玉明, 等. 实体器官移植后细小病毒B19感染导致单纯红细胞再生障碍性贫血3例并文献复习[J]. 中华实验和临床病毒学杂志, 2020, 34(5): 543-546. DOI: 10.3760/cma.j.cn112866-20191230-00210.

    ZHANG H, XIAO X, LI YM, et al. Three cases of pure red cell aplasia caused by parvovirus B19 infection after solid organ transplantation and literature review[J]. Chin J Exp Clin Virol, 2020, 34(5): 543-546. DOI: 10.3760/cma.j.cn112866-20191230-00210.
    [14]
    ALTHEABY A, ALOTAIBI M, ALAJLAN N, et al. Parvovirus B19 infection due to over immunosuppression in kidney transplant recipients: case reports and literature review[J]. Case Rep Transplant, 2021: 7651488. DOI: 10.1155/2021/7651488.
    [15]
    PORIGNAUX R, VUIBLET V, BARBE C, et al. Frequent occurrence of parvovirus B19 DNAemia in the first year after kidney transplantation[J]. J Med Virol, 2013, 85(6): 1115-1121. DOI: 10.1002/jmv.23557.
    [16]
    THONGPRAYOON C, KHOURY NJ, BATHINI T, et al. Epidemiology of parvovirus B19 and anemia among kidney transplant recipients: a Meta-analysis[J]. Urol Ann, 2020, 12(3): 241-247. DOI: 10.4103/UA.UA_89_19.
    [17]
    MENDE M, SOCKEL K. Parvovirus B19 infection[J]. N Engl J Med, 2018, 379(24): 2361. DOI: 10.1056/NEJMicm1807156.
    [18]
    YU Y, WEI C, LYU J, et al. Donor-derived human parvovirus B19 infection in kidney transplantation[J]. Front Cell Infect Microbiol, 2021, 11: 753970. DOI: 10.3389/fcimb.2021.753970.
    [19]
    BAEK CH, KIM H, YANG WS, et al. Risk factors and long-term outcomes of parvovirus B19 infection in kidney transplant patients[J]. Transpl Infect Dis, 2017, 19(5). DOI: 10.1111/tid.12754.
    [20]
    KOOISTRA K, MESMAN HJ, DE WAAL M, et al. Epidemiology of high-level parvovirus B19 viraemia among Dutch blood donors, 2003-2009[J]. Vox Sang, 2011, 100(3): 261-266. DOI: 10.1111/j.1423-0410.2010.01423.x.
    [21]
    耿彦生, 张印法. 血液、血制品与人类微小病毒B19的传播[J]. 疾病控制杂志, 2007, 11(5): 516-519. DOI: 10.3969/j.issn.1674-3679.2007.05.022.

    GEN YS, ZHANG YF. Human parvovirus B19 and the safety of blood and blood-derived products[J]. Chin J Dis Control Prev, 2007, 11(5): 516-519. DOI: 10.3969/j.issn.1674-3679.2007.05.022.
    [22]
    ZHANG W, KE L, CHANGQING L, et al. Parvovirus B19V DNA contamination in Chinese plasma and plasma derivatives[J]. J Transl Med, 2012, 10: 194. DOI: 10.1186/1479-5876-10-194.
    [23]
    BARZON L, MURER L, PACENTI M, et al. Detection of viral DNA in kidney graft preservation and washing solutions is predictive of posttransplant infections in pediatric recipients[J]. J Infect Dis, 2009, 200(9): 1425-1433. DOI: 10.1086/644504.
    [24]
    熊睿, 丁利民, 柳祝菁, 等. 肾移植后细小病毒B19感染所致贫血的诊疗策略[J/CD]. 实用器官移植电子杂志, 2021, 9(3): 249-252. DOI: 10.3969/j.issn.2095-5332.2021.03.019.

    XIONG R, DING LM, LIU ZJ, et al. Diagnosis and treatment strategies for anemia caused by parvovirus B19 infection after kidney transplantation[J/CD]. Pract J Organ Transplant(Electr Vers), 2021, 9(3): 249-252. DOI: 10.3969/j.issn.2095-5332.2021.03.019.
    [25]
    KAUFFMANN M, BOBOT M, DANIEL L, et al. Parvovirus B19 infection and kidney injury: report of 4 cases and analysis of immunization and viremia in an adult cohort of 100 patients undergoing a kidney biopsy[J]. BMC Nephrol, 2020, 21(1): 260. DOI: 10.1186/s12882-020-01911-9.
    [26]
    BARZON L, MURER L, PACENTI M, et al. Investigation of intrarenal viral infections in kidney transplant recipients unveils an association between parvovirus B19 and chronic allograft injury[J]. J Infect Dis, 2009, 199(3): 372-380. DOI: 10.1086/596053.
    [27]
    ABDELRAHMAN D, AL-SADEQ DW, SMATTI MK, et al. Prevalence and phylogenetic analysis of parvovirus (B19V) among blood donors with different nationalities residing in Qatar[J]. Viruses, 2021, 13(4): 540. DOI: 10.3390/v13040540.
    [28]
    胡娜娜, 许书添, 董建华, 等. 肾移植术后人细小病毒B19感染[J]. 肾脏病与透析肾移植杂志, 2018, 27(6): 589-593. DOI: 10.3969/j.issn.1006-298X.2018.06.020.

    HU NN, XU ST, DONG JH, et al. Human parvovirus B19 infection after renal transplantation[J]. Chin J Nephrol Dial Transplant, 2018, 27(6): 589-593. DOI: 10.3969/j.issn.1006-298X.2018.06.020.
    [29]
    DAS P, CHATTERJEE K, CHATTOPADHYAY NR, et al. Evolutionary aspects of parvovirus B-19V associated diseases and their pathogenesis patterns with an emphasis on vaccine development[J]. Virusdisease, 2019, 30(1): 32-42. DOI: 10.1007/s13337-019-00525-6.
    [30]
    ROSADO-CANTO R, CARRILLO-PÉREZ DL, JIMÉNEZ JV, et al. Treatment strategies and outcome of parvovirus B19 infection in kidney transplant recipients: a case series and literature review of 128 patients[J]. Rev Invest Clin, 2019, 71(4): 265-274. DOI: 10.24875/RIC.19002921.
    [31]
    HAZEBROEK MR, HENKENS MTHM, RAAFS AG, et al. Intravenous immunoglobulin therapy in adult patients with idiopathic chronic cardiomyopathy and cardiac parvovirus B19 persistence: a prospective, double-blind, randomized, placebo-controlled clinical trial[J]. Eur J Heart Fail, 2021, 23(2): 302-309. DOI: 10.1002/ejhf.2082.
    [32]
    WASSERMAN RL. Immunoglobulin replacement for primary immunodeficiency: indications for initiating and continuing treatment[J]. Allergy Asthma Proc, 2021, 42(6): 489-494. DOI: 10.2500/aap.2021.42.210082.
    [33]
    CRABOL Y, TERRIER B, ROZENBERG F, et al. Intravenous immunoglobulin therapy for pure red cell aplasia related to human parvovirus B19 infection: a retrospective study of 10 patients and review of the literature[J]. Clin Infect Dis, 2013, 56(7): 968-977. DOI: 10.1093/cid/cis1046.
    [34]
    张晓伟, 张雷, 赵闻雨, 等. 肾移植术后微小病毒B19感染22例临床治疗经验[J]. 中华器官移植杂志, 2019, 40(6): 323-327. DOI: 10.3760/cma.j.issn.0254-1785.2019.06.002.

    ZHANG XW, ZHANG L, ZHAO WY, et al. Parvovirus B19 infection in patients after renal transplantation: a report of 22 cases[J]. Chin J Organ Transplant, 2019, 40(6): 323-327. DOI: 10.3760/cma.j.issn.0254-1785.2019.06.002.
    [35]
    BUA G, CONTI I, MANARESI E, et al. Antiviral activity of brincidofovir on parvovirus B19[J]. Antiviral Res, 2019, 162: 22-29. DOI: 10.1016/j.antiviral.2018.12.003.
    [36]
    MANARESI E, GALLINELLA G. Advances in the development of antiviral strategies against parvovirus B19[J]. Viruses, 2019, 11(7): 659. DOI: 10.3390/v11070659.
    [37]
    BARAL A, POUDEL B, AGRAWAL RK, et al. Pure red cell aplasia caused by parvo B19 virus in a kidney transplant recipient[J]. JNMA J Nepal Med Assoc, 2012, 52(186): 75-78. http://jnma.com.np/jnma/index.php/jnma/article/download/73/345
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(1)  / Tables(3)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (1376) PDF downloads(325) Cited by()
    Proportional views
    Related

    WeChat Subscription Account

    Wechat Service Account

    Contact Us
    • Tel：020-38736410
    • Email: organtranspl@163.com
    • Address：The Third Affiliated Hospital of Sun Yat-sen University, No. 600, Tianhe Road, Tianhe District, Guangzhou
    • Editorial Office of Organ Transplantation  粤ICP备2021030844号
    Links

    Supported by: Beijing Renhe Information Technology Co. Ltd    

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return